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Platelet.derived growth factor receptors in the kidney—Upregulated
expression in inflammation. Major features of a long-standing inflamma-
tion in the kidney are vascular proliferation, glomeruloscierosis, inter-
stitial fibrosis and tubular atrophy, leading to a gradual deterioration of
the renal function. In this study we have investigated the expression of
B-type receptors for platelet-derived growth factor (PDGF) in frozen
sections from normal and inflamed kidneys. Immunohistochemical
techniques, employing two monoclonal antibodies specific for PDGF
B-type receptors, were used. The specimens investigated were 15
kidneys removed by transplantectomy because of chronic rejection, 20
cases of glomerulonephntis with crescent formation, mesangial prolif-
eration or non-proliferative glomerulonephritis. and six normal kidneys.
In parallel we characterized cellular infiltrates and class II transplanta-
tion antigen expression in the inflamed kidneys. An enhanced PDGF
receptor expression was found on intimal cells and on smooth muscle
cells of the proliferating vessels, on glomerular cells in glomeruli with
mesangial proliferation, and on fibroblast-like cells in the proximity of
clusters of infiltrating macrophages and T-lymphocytes of the intersti-
tial tissue. Induction of PDGF receptor expression may render cells
responsive to stimulation by PDGF, released from PDGF-producing
cells, such as activated macrophages and from platelets. Our data
suggest that PDGF is involved in the proliferation of mesenchymal cells
that is seen in rejected kidney transplants and glomerulonephritis.
The effects of a long-standing inflammation in the kidney are
similar, whether the origin of the inflammation is a rejection
process or an autoimmune disease. The acute rejection of a
renal transplant is morphologically characterized by an invasion
of activated T-lymphocytes [1, 2] initiating a recruitment of
mononuclear inflammatory cells [3, 41. Thus, activated T-
lymphocytes and activated macrophages are frequently dis-
closed within the rejected transplants [1—4], and in particular,
activated monocytes and macrophages are predominant in
chronic rejection. A prominent feature in the chronic rejection
of renal transplants is also a proliferation of vascular cells and
fibrotic or sclerotic scarring.
In rapidly progressive glomerulonephritis various degrees of
mesangial expansion, crescent formation and glomerulosclero-
sis are found [5], along with an invasion of activated macro-
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phages [6, 7] and T-lymphocytes and a presence of platelet
granule proteins [8]. These processes may contribute to the
damage of the functional unit of the kidney and cause a terminal
deterioration of the renal function.
PDGF [reviewed in 9, 10] is a major mitogen in serum for
smooth muscle cells, fibroblasts, as well as for mesangial cells
in the glomeruli [11]. Structurally, PDGF is a dimeric molecule
composed of two disulphide-bonded homologous polypeptide
chains, denoted A and B [9, 10]. All three possible dimeric
isoforms, PDGF-AA, PDGF-AB and PDGF-BB, have been
identified and purified from natural sources [12]. PDGF is
stored in blood platelets and released upon blood coagulation.
In addition, PDGF is synthesized and released by a variety of
normal and malignant cell types, including activated macro-
phages [13, 141.
Receptors for PDGF have been detected on various types of
cultured cells, including smooth muscle cells and fibroblasts
[15]. The presence of two types of PDGF receptors, denoted
type A and type B have recently been reported [16, 17]. The
B-type PDGF receptor has been shown to transduce a potent
mitogenic signal [161.
Monoclonal antibodies specific for B-type PDGF receptors
have recently been described [18]. These reagents have proven
useful to immunohistochemically localize PDGF B-type recep-
tor in tissue sections [19, 20]. Immunohistochemical studies
revealed that the expression of B-type PDGF receptors varies
in tissues and is generally higher in tissues affected by chronic
inflammation [20]. Earlier we have reported that an increased
expression of B-type PDGF receptors was observed in rejected
kidney transplants [20]. In the present study we report on a
more detailed study of B-type PDGF receptor distribution in
sections from normal kidneys, rejected renal transplants and
kidneys affected by glomerulonephritis.
Methods
Normal renal tissue was obtained from six kidneys which had
been perfused with a standard preservation solution, but for
technical reasons could not be used for transplantation. Alto-
gether 15 renal transplants were obtained by transplantectomy
in conjunction with chronic rejection. Renal specimen from
patients with glomerulonephritis were obtained by kidney bi-
opsy, using a tru-cut needle with an inner diameter of 1.2 mm
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Fig. 1. PDGF receptor type-B expression in renal specimen using monoclonal antibodies recognizing the receptor and immunohistochemica!
PAP-technique with hematoxyline counter-staining. Photomicrographs show stainings of an artery (A) and a glomeruli (B) from a normal kidney.
In transplanted kidneys removed because of chronic rejection, there was a strong staining on intimal cells in the proliferating vessels (C) and on
smooth muscle cells in the same vessels (D). Intense glomerular stainings were found in glomeruli of transplanted kidneys (E) and in
glomerulonephritis with mesangial proliferation (F) in contrast to fully sclerosed glomeruhi (G). In non-proliferative glomerulonephritis, the
glomerular PDGF receptor expression was weaker (H). Color reproductions were supported by Wellcome Foundation Ltd, Sweden.
[21]. The histological examination revealed crescentic glomer-
ulonephritis in nine cases and focal crescent formation with
mesangial proliferation in eight cases. Totally scierosed glomer-
uli were also found in these kidneys. For comparison four cases
of non-proliferative glomerulonephritis, that is, two cases with
membranous nephropathy and two cases with systemic lupus,
without mesangial proliferation, were included.
The tissues were rapidly frozen in isopentane and stored at
—70°C. Six jsm sections were cut in a cryostat and the sections
were fixed in acetone. The sections were subsequently stained
using the peroxidase-anti-peroxidase (PAP) procedure [22].
Recently developed monoclonal antibodies from a mouse hy-
bridoma reacting with the B-type PDGF receptor [18], denoted
PDGFR-Bl and -B2, were used as primary antibodies, the
development of which was based on purified porcine PDGF
receptors [23]. The infiltration of inflammatory cells was char-
acterized by a commercially available monoclonal antibody
(Becton-Dickinson, Mountain View, California, USA) reacting
with T-lymphocytes (anti-Leu4) and a monoclonal antibody
(RFD7) recognizing macrophages [24]. For the disclosure of
HLA-DR, -DP and -DQ antigens a set of commercially available
monoclonal antibodies was used (Becton-Dickinson). The sec-
ondary antibody was a swine anti-mouse IgG (Dakopatts,
Glostrup, Denmark). In the third step complexes formed of
peroxidase and anti-peroxidase antibodies (Dakopatts) were
used. A peroxidase reaction with carbazole as the substrate was
used in a final step. No peroxidase staining was found when the
primary antibodies were omitted.
Results
Immunohistochemical stainings of sections of normal renal
tissue using the PDGFR-B 1 and PDGFR-B2 antibodies revealed
that B-type PDGF receptor expression was low or absent on
connective tissue and vascular smooth muscle cells in these
renal tissues (Fig. IA). In three out of six of the normal renal
specimens there was a weak staining on glomerular cells;
apparently these were mesangial cells (Fig. lB; Table 1).
In sections of the renal transplants with chronic rejection
intense stainings with the anti-PDGF receptor antibody were
found on several cells. The most prominent features was an
intense staining in the vascular wall of vessels undergoing an
intimal proliferation. There was a scattered expression of
PDGF receptors on cells throughout the intima (Fig. IC),
especially in the proximity of invading macrophages and,
occasionally, also along the innermost lining of the intima.
Expression of PDGF receptors regularly occurred on the vas-
cular smooth muscle cells (Fig. lD) of small arteries and
arterioles in proliferating vessels. Stainings with the macro-
phage-specific monoclonal antibody RFD7 on adjacent sections
revealed a positive reaction scattered in the vascular wall. The
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Table 1. Semi-quantitative evaluation of intensity of glomerular
stainings using PDGF-receptor antibody type B
Classification of kidneys (N)
Staifling intensity
None Weak Strong
Normal (6) 3 3 0
Transplanted kidneys, chronic rejection (13) 2 5 6
Crescentic, glomerulonephritis (9) 0 5 4
Focal segmental glomerulosclerosis 0 1 6
with mesangial proliferation (7)
Non-proliferative glomerulonephritis (4) 0 3 1
N = number of specimens with glomeruli in the biopsy which could
be evaluated
intimal cells and the macrophages both expressed HLA-DR,
whereas expression of HLA-DP and HLA-DQ were only found
on infiltrating inflammatory cells (not shown).
An intense staining with the anti-PDGF-receptor antibody
was found within glomeruli (Table 1) in most of the rejected
transplants (Fig. 1E) and in glomeruli with a mesangial prolif-
eration in glomerulonephritis (Fig. 1F). The identity of the
glomerular cells that expressed PDGF receptor is uncertain, but
based on the morphology of the cells they are likely to be
mesangial cells. An invasion of macrophages was frequently
found in the glomeruli both in rejected transplants and in
glomerulonephritis, but the glomerular cells expressing the
PDGF receptor were not stained with the RFD7-antibody
recognizing macrophages. PDGF receptor expression was not
found in fully developed crescents, or in totally sclerosed
glomeruli (Fig. lG). In non-proliferative glomerulonephritis the
glomerular stainings were weaker than in cases with mesangial
proliferation (Fig. 1H; Table 1). Glomerular cells, both in
rejected transplants and in glomerulonephritis also expressed
HLA-DR, but not HLA-DP or HLA-DQ (not shown).
Clusters of lymphocytes (anti-Leu4) and macrophages (anti-
RFD7) commonly appeared in the interstitium, both in trans-
planted kidneys and in the cases of crescentic glomerulonephri-
tis. Within these areas the PDGF receptor type B was
expressed, supposedly on interstitial connective tissue cells. A
positive expression of HLA-DR, -DP and DQ was disclosed on
T-lymphocytes and on macrophages invading these kidneys
(not shown).
Discussion
The present investigation demonstrates that B-type PDGF
receptors occur on various cell types in the inflamed kidney. In
the vascular wall of rejected kidney transplants, where a
proliferation of intimal cells appeared, there was a prominent
B-type PDGF receptor expression. The receptor was expressed
both on smooth muscle cells and scattered among proliferating
intimal cells, including the innermost intimal lining. In these
vessels there was also a simultaneous occurrence of activated
macrophages [3, 4, 25]. These findings are analogous to what
has been reported on PDGF receptor expression in the vessels
in chronic synovitis [19, 20]. In contrast, in normal renal tissue
there was basically no staining on any cell type in the vascular
wall.
There was also an intense staining with the anti-PDGF-
receptor antibody on glomerular cells both in chronic rejection
of renal transplants and in glomerulonephritis with mesangial
proliferation. In the normal kidneys investigated, a weak stain-
ing was found in 3/6 kidneys, whereas in rejected transplants
and in glomeruli with mesangial proliferation the staining was
far more distinct and intense. In non-proliferative forms of
glomerulonephritis the glomerular stainings had a weaker ap-
pearance. The localization and the morphological appearance of
the cells in the glomeruli that expressed the PDGF receptors
makes it likely that they are mesangial cells. Such an enhanced
PDGF receptor expression on glomerular mesangial cells would
be of particular interest, since mesangial cell proliferation is a
common feature in many forms of glomerulonephritis. Mesan-
gial cells have been shown both to release and respond to
interleukin-l [26, 27] and PDGF [11, 28] upon activation in
vitro. An autocrine or paracrine stimulation of mesangial cell
proliferation may thus occur in this type of inflammatory
process. Invading activated macrophages [3—7] found in the
glomeruli may be a source of PDGF-like mitogens, along with
the possibility of trapped platelets [8, 29]. Thus, PDGF may be
involved in mesangial cell proliferation and in the subsequent
development of glomerulosclerosis in chronic glomerular in-
flammation.
There was a positive staining with the anti-PDGF receptor
antibody in the interstitium both in chronically rejected renal
transplants and in crescentic glomerulonephritis. In the normal
kidneys examined in this study, B-type PDGF receptors were
not found in the interstitial compartment, whereas in the
inflamed kidneys receptor expression was found in the proxim-
ity of clusters of activated lymphocytes and macrophages,
which were abundant in the interstitium [3, 4, 6, 7]. Since
interstitial fibrosis and tubular atrophy are features of chroni-
cally rejected renal transplants and of kidneys undergoing a
longstanding autoimmune inflammation, it is possible that
PDGF also has a role in the development of this type of fibrosis.
The mechanism by which PDGF receptors become induced
or upregulated in conjunction with an inflammatory process is
not known. The observed staining patterns suggest that cyto-
kines released from activated macrophages or T-lymphocytes
may play a role in the induction of B-type PDGF receptor
expression [20]. The presence of activated macrophages, with
the potential of secreting a PDGF-like peptide, did not seem to
downregulate the receptor expression of adjacent parenchymal
cells, however. In the inflamed kidney PDGF may be supplied
by monocytes, macrophages or platelets and stimulate cellular
growth via binding to the induced or upregulated PDGF recep-
tor on various cell types. A PDGF-driven mechanism involved
in the proliferation of vascular cells, the development of fibrosis
in chronic rejection of transplanted kidneys and in the devel-
opment of crescents and glomeruloscierosis in glomerulone-
phritis can be anticipated to be of potential importance for the
destructive remodelling taking place in the inflamed kidney.
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